British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant in Singapore to manufacture next-generation drugs to treat cancer.
This article was originally published on this website.
AstraZeneca to build $1.5 bln cancer drug facility in Singapore
